Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus

Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance progr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2001-09, Vol.46 (9), p.1892-1898
Hauptverfasser: FITZGERALD, Rebecca C, SAEED, Ibtisan T, KHOO, David, FARTHING, Michael J. G, BURNHAM, W. Rodney
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1898
container_issue 9
container_start_page 1892
container_title Digestive diseases and sciences
container_volume 46
creator FITZGERALD, Rebecca C
SAEED, Ibtisan T
KHOO, David
FARTHING, Michael J. G
BURNHAM, W. Rodney
description Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.
doi_str_mv 10.1023/A:1010678913481
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71195666</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71195666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</originalsourceid><addsrcrecordid>eNpd0E1LJDEQBuAgLjq6nr1JENTTaCpJJ93e3MGPBWFB1nOTSVdrpGcyptLK_vvN4IjgqerwVFFvMXYI4hyEVBdXlyBAGFs3oHQNW2wClVVTWZl6m00EmNIDmF22R_QihGgsmB22C0VVWsOEhYfwFFMcidOY3jAMg1t65KsUc_Rx4GHpEzpC4h1m9DnEJY8992Ny8wG5X-tE3BFFH1zGjr-H_Mx_uZQw5zPiSHH17J5G-sl-9G4gPNjUffZ4c_13dje9_3P7e3Z1P_UKRJ4aLzolPFR9Bb1p1Fwo0avGWlfVPaD22tdoTdcpV0sndTd3ope2TFndCOvVPjv92FsyvI5IuV0E8rgOhiVnawGayhhT4PE3-BLHtCy3tRK0krW1dUFHGzTOF9i1qxQWLv1rPz9YwMkGOPJu6FP5SKAvp0FLC1L9B08ZgJs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214328778</pqid></control><display><type>article</type><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</creator><creatorcontrib>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</creatorcontrib><description>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1023/A:1010678913481</identifier><identifier>PMID: 11575441</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adenocarcinoma - etiology ; Adenocarcinoma - prevention &amp; control ; Adult ; Aged ; Aged, 80 and over ; Barrett Esophagus - complications ; Biological and medical sciences ; Cost-Benefit Analysis ; Esophageal Neoplasms - etiology ; Esophageal Neoplasms - prevention &amp; control ; Esophagoscopy ; Esophagus ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Mass Screening - economics ; Mass Screening - methods ; Medical sciences ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Tumors</subject><ispartof>Digestive diseases and sciences, 2001-09, Vol.46 (9), p.1892-1898</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Sep 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14142712$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11575441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FITZGERALD, Rebecca C</creatorcontrib><creatorcontrib>SAEED, Ibtisan T</creatorcontrib><creatorcontrib>KHOO, David</creatorcontrib><creatorcontrib>FARTHING, Michael J. G</creatorcontrib><creatorcontrib>BURNHAM, W. Rodney</creatorcontrib><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</description><subject>Adenocarcinoma - etiology</subject><subject>Adenocarcinoma - prevention &amp; control</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Barrett Esophagus - complications</subject><subject>Biological and medical sciences</subject><subject>Cost-Benefit Analysis</subject><subject>Esophageal Neoplasms - etiology</subject><subject>Esophageal Neoplasms - prevention &amp; control</subject><subject>Esophagoscopy</subject><subject>Esophagus</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening - economics</subject><subject>Mass Screening - methods</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0E1LJDEQBuAgLjq6nr1JENTTaCpJJ93e3MGPBWFB1nOTSVdrpGcyptLK_vvN4IjgqerwVFFvMXYI4hyEVBdXlyBAGFs3oHQNW2wClVVTWZl6m00EmNIDmF22R_QihGgsmB22C0VVWsOEhYfwFFMcidOY3jAMg1t65KsUc_Rx4GHpEzpC4h1m9DnEJY8992Ny8wG5X-tE3BFFH1zGjr-H_Mx_uZQw5zPiSHH17J5G-sl-9G4gPNjUffZ4c_13dje9_3P7e3Z1P_UKRJ4aLzolPFR9Bb1p1Fwo0avGWlfVPaD22tdoTdcpV0sndTd3ope2TFndCOvVPjv92FsyvI5IuV0E8rgOhiVnawGayhhT4PE3-BLHtCy3tRK0krW1dUFHGzTOF9i1qxQWLv1rPz9YwMkGOPJu6FP5SKAvp0FLC1L9B08ZgJs</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>FITZGERALD, Rebecca C</creator><creator>SAEED, Ibtisan T</creator><creator>KHOO, David</creator><creator>FARTHING, Michael J. G</creator><creator>BURNHAM, W. Rodney</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><author>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenocarcinoma - etiology</topic><topic>Adenocarcinoma - prevention &amp; control</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Barrett Esophagus - complications</topic><topic>Biological and medical sciences</topic><topic>Cost-Benefit Analysis</topic><topic>Esophageal Neoplasms - etiology</topic><topic>Esophageal Neoplasms - prevention &amp; control</topic><topic>Esophagoscopy</topic><topic>Esophagus</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening - economics</topic><topic>Mass Screening - methods</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FITZGERALD, Rebecca C</creatorcontrib><creatorcontrib>SAEED, Ibtisan T</creatorcontrib><creatorcontrib>KHOO, David</creatorcontrib><creatorcontrib>FARTHING, Michael J. G</creatorcontrib><creatorcontrib>BURNHAM, W. Rodney</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FITZGERALD, Rebecca C</au><au>SAEED, Ibtisan T</au><au>KHOO, David</au><au>FARTHING, Michael J. G</au><au>BURNHAM, W. Rodney</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>46</volume><issue>9</issue><spage>1892</spage><epage>1898</epage><pages>1892-1898</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>11575441</pmid><doi>10.1023/A:1010678913481</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2001-09, Vol.46 (9), p.1892-1898
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_miscellaneous_71195666
source MEDLINE; SpringerLink Journals
subjects Adenocarcinoma - etiology
Adenocarcinoma - prevention & control
Adult
Aged
Aged, 80 and over
Barrett Esophagus - complications
Biological and medical sciences
Cost-Benefit Analysis
Esophageal Neoplasms - etiology
Esophageal Neoplasms - prevention & control
Esophagoscopy
Esophagus
Female
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Male
Mass Screening - economics
Mass Screening - methods
Medical sciences
Middle Aged
Prospective Studies
Retrospective Studies
Tumors
title Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T01%3A05%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rigorous%20surveillance%20protocol%20increases%20detection%20of%20curable%20cancers%20associated%20with%20Barrett's%20esophagus&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=FITZGERALD,%20Rebecca%20C&rft.date=2001-09-01&rft.volume=46&rft.issue=9&rft.spage=1892&rft.epage=1898&rft.pages=1892-1898&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1023/A:1010678913481&rft_dat=%3Cproquest_pubme%3E71195666%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214328778&rft_id=info:pmid/11575441&rfr_iscdi=true